Elanix Biotechnologies AG

Declaration of Voting Results & Voting Rights Announcements • Mar 22, 2017

News Details

Voting Rights Announcements | 22 March 2017 17:10

Correction of a release from 17.03.2017, 09:00 CET/CEST – Elanix Biotechnologies AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Elanix Biotechnologies AG

22.03.2017 / 17:10

Dissemination of a Voting Rights Announcement transmitted by DGAP – a service of EQS Group AG.

The issuer is solely responsible for the content of this announcement.

---

Correction of a notification of Major Holding published on 17.03.2017

1. Details of issuerElanix Biotechnologies AG

Domstr. 22

14482 Potsdam

Germany

2. Reason for notification

	Acquisition/disposal of shares with voting rights
	Acquisition/disposal of instruments
X	Change of breakdown of voting rights
	Other reason:

3. Details of person subject to the notification obligation

Name:	City and country of registered office:
Mr Prof. Wassim Raffoul

4. Names of shareholder(s)

holding directly 3% or more voting rights, if different from 3.

Lee-Ann Laurent-Applegate, Corinne Scaletta, Tomas Svoboda

5. Date on which threshold was crossed or reached09 March 2017

6. Total positions

	% of voting rights attached to shares (total of 7.a.)	% of voting rights through instruments (total of 7.b.1 + 7.b.2)	total of both in % (7.a. + 7.b.)	total number of voting rights of issuer
Resulting situation	49.99 %	0.00 %	49.99 %	6799200
Previous notification	65.25 %	0.00 %	65.25 %	/

7. Notified details of the resulting situation

a. Voting rights attached to shares (Sec.s 21, 22 WpHG)

ISIN	absolute		in %
	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)	direct (Sec. 21 WpHG)	indirect (Sec. 22 WpHG)
DE000A0WMJQ4	172028	3227469	2.52 %	47.47 %
Total	3399497		49.99 %

b.1. Instruments according to Sec. 25 para. 1 No. 1 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Voting rights absolute	Voting rights in %
				%
		Total		%

b.2. Instruments according to Sec. 25 para. 1 No. 2 WpHG

Type of instrument	Expiration or maturity date	Exercise or conversion period	Cash or physical settlement	Voting rights absolute	Voting rights in %
					%
			Total		%

8. Information in relation to the person subject to the notification obligation

X	Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.).
	Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name	% of voting rights (if at least held 3% or more)	% of voting rights through instruments (if at least held 5% or more)	Total of both (if at least held 5% or more)

9. In case of proxy voting according to Sec. 22 para. 3 WpHG

Date of general meeting:
Holding position after general meeting:	% (equals voting rights)

10. Other explanatory remarks:

---

22.03.2017 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de

---

Language:	English
Company:	Elanix Biotechnologies AG
	Domstr. 22
	14482 Potsdam
	Germany

End of News	DGAP News Service